Literature DB >> 19787230

Identification and characterization of cancer stem-like cells from primary carcinoma of the cervix uteri.

Dingqing Feng1, Cheng Peng, Cairong Li, Ying Zhou, Min Li, Bin Ling, Haiming Wei, Zhigang Tian.   

Abstract

Like many other solid tumors, cervical cancer contains a heterogeneous population of cancer cells. Several investigators have identified putative stem cells from solid tumors and cancer cell lines via the capacity to self renew and drive tumor formation. The aim of this study was to identify and characterize a cancer stem-like cell population from primary carcinoma of the cervix uteri. Cervical carcinoma from 19 patients staged I-II following International Federation of Gynecology and Obstetrics (FIGO) criteria were disaggregated and subjected to growth conditions selective for stem cells. Eight of nineteen tumor-derived cultures encompassed stem-like cells capable of self-renewal, extensive proliferation as clonal non-adherent spherical clusters. Cell markers of spheroid were identified as CD44+CK17+. Cell survival assays showed the sphere-forming cells were only 48% inhibited by doxorubicin whereas 78% inhibited by paclitaxel. Chemo-resistance may partly attribute to the exclusive expression of ABC transporter. To investigate the tumorigenicity of these stem-like cells, xenoengraftment of 10(5) dissociated spheroid cells allowed full recapitulation of the original tumor, whereas the same amount of tumor cells without non-adherent spheroid selection remained non-tumorigenic. Stemness properties of these spheroid cells were further established by reverse transcription-PCR and Western blotting, demonstrating the expression of embryonic and adult stemness-related genes (Oct-4, Piwil2, C-myc, Stat3 and Sox2). Based on these findings, we assert that cervical cancer contain a subpopulation of tumor initiating cells with stem-like properties, thus facilitating the approach to therapeutic strategies aimed at eradicating the tumorigenic subpopulation within cervical cancer.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19787230     DOI: 10.3892/or_00000545

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  53 in total

Review 1.  Cervical cancer stem cells.

Authors:  Tingting Yao; Rongbiao Lu; Yizhen Zhang; Ya Zhang; Chenyang Zhao; Rongchun Lin; Zhongqiu Lin
Journal:  Cell Prolif       Date:  2015-12       Impact factor: 6.831

Review 2.  Embryonic stem cell-specific signature in cervical cancer.

Authors:  Jorge Organista-Nava; Yazmín Gómez-Gómez; Patricio Gariglio
Journal:  Tumour Biol       Date:  2013-10-28

3.  CD66+ cells in cervical precancers are partially differentiated progenitors with neoplastic traits.

Authors:  Chitra Pattabiraman; Shiyuan Hong; Vignesh K Gunasekharan; Annapurna Pranatharthi; Jeevisha Bajaj; Sweta Srivastava; H Krishnamurthy; Aswathy Ammothumkandy; Venkat G Giri; Laimonis A Laimins; Sudhir Krishna
Journal:  Cancer Res       Date:  2014-09-29       Impact factor: 12.701

4.  Differential expression of Oct4 in HPV-positive and HPV-negative cervical cancer cells is not regulated by DNA methyltransferase 3A.

Authors:  Dongbo Liu; Peng Zhou; Li Zhang; Gengze Wu; Yingru Zheng; Fengtian He
Journal:  Tumour Biol       Date:  2011-06-15

5.  Clinical significance of the stem cell gene Oct-4 in cervical cancer.

Authors:  Yanyan Yang; Yimin Wang; Chunxia Yin; Xiuying Li
Journal:  Tumour Biol       Date:  2014-02-16

6.  Keratin 17 in premalignant and malignant squamous lesions of the cervix: proteomic discovery and immunohistochemical validation as a diagnostic and prognostic biomarker.

Authors:  Luisa F Escobar-Hoyos; Jie Yang; Jiawen Zhu; Julie-Ann Cavallo; Haiyan Zhai; Stephanie Burke; Antonius Koller; Emily I Chen; Kenneth R Shroyer
Journal:  Mod Pathol       Date:  2013-09-20       Impact factor: 7.842

7.  EGFR inhibitors prevent induction of cancer stem-like cells in esophageal squamous cell carcinoma by suppressing epithelial-mesenchymal transition.

Authors:  Fumiyuki Sato; Yoshimasa Kubota; Mitsuteru Natsuizaka; Osamu Maehara; Yutaka Hatanaka; Katsuji Marukawa; Katsumi Terashita; Goki Suda; Shunsuke Ohnishi; Yuichi Shimizu; Yoshito Komatsu; Shinya Ohashi; Shingo Kagawa; Hideaki Kinugasa; Kelly A Whelan; Hiroshi Nakagawa; Naoya Sakamoto
Journal:  Cancer Biol Ther       Date:  2015-04-21       Impact factor: 4.742

8.  Identification of Piwil2-like (PL2L) proteins that promote tumorigenesis.

Authors:  Yin Ye; De-Tao Yin; Li Chen; Quansheng Zhou; Rulong Shen; Gang He; Qingtao Yan; Zhenyu Tong; Andrew C Issekutz; Charles L Shapiro; Sanford H Barsky; Haifan Lin; Jian-Jian Li; Jian-Xin Gao
Journal:  PLoS One       Date:  2010-10-20       Impact factor: 3.240

9.  Epigenetic regulation of CpG promoter methylation in invasive prostate cancer cells.

Authors:  Lesley A Mathews; Elaine M Hurt; Xiaohu Zhang; William L Farrar
Journal:  Mol Cancer       Date:  2010-10-07       Impact factor: 27.401

10.  Loss of Keratin 17 induces tissue-specific cytokine polarization and cellular differentiation in HPV16-driven cervical tumorigenesis in vivo.

Authors:  R P Hobbs; A S Batazzi; M C Han; P A Coulombe
Journal:  Oncogene       Date:  2016-04-11       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.